Literature DB >> 8976867

p53: guardian of cellular senescence.

D Wynford-Thomas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8976867     DOI： 10.1002/(SICI)1096-9896(199610)180:2<118::AID-PATH673>3.0.CO;2-I

Source DB:  PubMed          Journal:  J Pathol        ISSN： 0022-3417            Impact factor:   7.996


× No keyword cloud information.
  14 in total

Review 1.  Telomerase: biological function and potential role in cancer management.

Authors:  V D Chatziantoniou
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

2.  An alternative lifestyle for immortalized oral keratinocytes.

Authors:  R R Reddel
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

3.  Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.

Authors:  Y Tang; I Horikawa; M Ajiro; A I Robles; K Fujita; A M Mondal; J K Stauffer; Z-M Zheng; C C Harris
Journal:  Oncogene       Date:  2012-07-09       Impact factor: 9.867

Review 4.  [Evaluation of cancer risk through genetic analysis?].

Authors:  A Luz
Journal:  Strahlenther Onkol       Date:  1997-09       Impact factor: 3.621

5.  Reinitiation of DNA synthesis and cell division in senescent human fibroblasts by microinjection of anti-p53 antibodies.

Authors:  V Gire; D Wynford-Thomas
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

6.  Wild-type and Hupki (human p53 knock-in) murine embryonic fibroblasts: p53/ARF pathway disruption in spontaneous escape from senescence.

Authors:  Catherine Whibley; Adam F Odell; Tatiana Nedelko; Gregor Balaburski; Maureen Murphy; Zhipei Liu; Louisa Stevens; John H Walker; Michael Routledge; Monica Hollstein
Journal:  J Biol Chem       Date:  2010-01-29       Impact factor: 5.157

7.  YY1 is a novel potential therapeutic target for the treatment of HPV infection-induced cervical cancer by arsenic trioxide.

Authors:  Guifen He; Qian Wang; Yuqi Zhou; Xiaohua Wu; Lan Wang; Nadire Duru; Xiangtao Kong; Pingzhao Zhang; Bo Wan; Long Sui; Qisang Guo; Jian-Jian Li; Long Yu
Journal:  Int J Gynecol Cancer       Date:  2011-08       Impact factor: 3.437

Review 8.  The impact of cellular senescence in cancer therapy: is it true or not?

Authors:  Yi Zhang; Jin-ming Yang
Journal:  Acta Pharmacol Sin       Date:  2011-09-12       Impact factor: 6.150

Review 9.  Disruptive chemicals, senescence and immortality.

Authors:  Amancio Carnero; Carmen Blanco-Aparicio; Hiroshi Kondoh; Matilde E Lleonart; Juan Fernando Martinez-Leal; Chiara Mondello; A Ivana Scovassi; William H Bisson; Amedeo Amedei; Rabindra Roy; Jordan Woodrick; Annamaria Colacci; Monica Vaccari; Jayadev Raju; Fahd Al-Mulla; Rabeah Al-Temaimi; Hosni K Salem; Lorenzo Memeo; Stefano Forte; Neetu Singh; Roslida A Hamid; Elizabeth P Ryan; Dustin G Brown; John Pierce Wise; Sandra S Wise; Hemad Yasaei
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

10.  Cellular senescence as a target in cancer control.

Authors:  Mar Vergel; Juan J Marin; Purificacion Estevez; Amancio Carnero
Journal:  J Aging Res       Date:  2010-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.